- Home
- MTEK vs EDSA Comparison
MTEK vs EDSA Comparison
Compare MTEK & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- EDSA
- Stock Information
- Founded
- MTEK 2008
- EDSA 2015
- Country
- MTEK Israel
- EDSA Canada
- Employees
- MTEK N/A
- EDSA N/A
- Industry
- MTEK
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- MTEK
- EDSA Health Care
- Exchange
- MTEK Nasdaq
- EDSA Nasdaq
- Market Cap
- MTEK N/A
- EDSA 13.8M
- IPO Year
- MTEK 2022
- EDSA N/A
- Fundamental
- Price
- MTEK $3.19
- EDSA $2.04
- Analyst Decision
- MTEK
- EDSA Strong Buy
- Analyst Count
- MTEK 0
- EDSA 2
- Target Price
- MTEK N/A
- EDSA $13.00
- AVG Volume (30 Days)
- MTEK 174.1K
- EDSA 14.6K
- Earning Date
- MTEK 08-27-2025
- EDSA 08-08-2025
- Dividend Yield
- MTEK N/A
- EDSA N/A
- EPS Growth
- MTEK N/A
- EDSA N/A
- EPS
- MTEK N/A
- EDSA N/A
- Revenue
- MTEK $6,078,953.00
- EDSA N/A
- Revenue This Year
- MTEK N/A
- EDSA N/A
- Revenue Next Year
- MTEK N/A
- EDSA N/A
- P/E Ratio
- MTEK N/A
- EDSA N/A
- Revenue Growth
- MTEK 50.80
- EDSA N/A
- 52 Week Low
- MTEK $1.45
- EDSA $1.55
- 52 Week High
- MTEK $6.47
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- MTEK 62.59
- EDSA 52.18
- Support Level
- MTEK $2.65
- EDSA $1.99
- Resistance Level
- MTEK $3.44
- EDSA $2.14
- Average True Range (ATR)
- MTEK 0.45
- EDSA 0.12
- MACD
- MTEK 0.02
- EDSA 0.02
- Stochastic Oscillator
- MTEK 57.47
- EDSA 58.62
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.